Bir ekosistem olarak kanser | Leslie Crews, PhD | TEDxSanDiegoSalon

Kanser, yalnızca yok edilecek tümör hücreleri olarak değil, bozulmuş bir ekosistem olarak da ele alınabilir. Konuşmacı Dr. Leslie Crews, ekoloji, kök hücre biyolojisi ve kanser araştırmalarından yararlanarak Yeni Zelanda'daki nesli tehlike altındaki kuşların bu bakış açısına nasıl ışık tutabileceğini anlatıyor. Konuşma, kan kanseri araştırmaları, bağışıklık yaşlanması ve yeni nesil tedaviler üzerine odaklanıyor. Bu TEDx konuşması, TED konferans formatı kullanılarak bağımsız biçimde düzenlenmiştir.

• Kanserin bozulmuş bir ekosistem olarak değerlendirilmesi
• Ekoloji, kök hücre biyolojisi ve kan kanseri araştırmalarından bakış açıları
• Bağışıklık yaşlanması ve yeni nesil tedaviler

What can endangered birds in New Zealand teach us about cancer? Drawing on insights from ecology, stem cell biology, and cancer research, Dr. Leslie Crews explores a new way of thinking about cancer: not simply as tumor cells to destroy, but as a disrupted ecosystem that may be restored. Through discoveries in blood cancer research, immune aging, and next-generation therapies, she shares how rebuilding cellular ecosystems could help shape the future of cancer treatment. www.crews-lab.com https://www.linkedin.com/in/lesliecrewsphd/ #bloodcancer #cancerecosystem #myeloma #TEDxSanDiego #TEDx #MooresCancerCenter #UCSD Dr. Leslie Crews is an Assistant Professor at UC San Diego and Co-Leader of the Hematologic Malignancies Research Program at the Moores Cancer Center. A third-generation native San Diegan, her first foray into scientific research was as a summer high school intern tasked with studying the behavior of fruit flies in a laboratory at the Salk Institute in La Jolla. She then trained at UCLA and UC San Diego in diverse biomedical research fields spanning neuroscience, eye disease, blood stem cell biology, geroscience, and cancer. Now her laboratory aims to uncover unifying biological circuitries that drive blood cancer regeneration and drug resistance. By targeting entire tumor ecosystems, her team is advancing new therapeutic strategies designed to reduce cancer burden while sparing healthy cells. Dr. Crews’ research is currently supported by an NCI R37 MERIT Award, a Blood Cancer United Scholar Award, and an American Society of Hematology Bridge Grant, among other national honors. www.crews-lab.com This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at https://www.ted.com/tedx